Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr366.10 DKK
Change Today -4.90 / -1.32%
Volume 2.5M
NOVOB On Other Exchanges
New York
As of 11:07 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jesper Brandgaard MSc

Chief Financial Officer, Executive Vice President, Member of Executive Management, Chairman of The Board - Novo Nordisk Engineering A/S and Chairman of The Board - Novo Nordisk IT A/S, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Jesper Brandgaard, M.Sc. has been the Chief Financial Officer and Executive Vice President of Novo Nordisk A/S since November 2000 and serves as its Member of Executive Management. Mr. Brandgaard joined Novo Nordisk A/S in 1999 as a senior Vice President of Finance. He served as the Chairman of the Board at NNE Pharmaplan A/S (formerly, Novo Nordisk Engineering A/s) and Novo Nordisk IT A/S, subsidiaries of Novo Nordisk A/S. He has been the Chairman of NNIT A/S since ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880


Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Former Chairman
Chairman of the Board


MS 1990
Copenhagen Business School
MBA 1995
Copenhagen Business School

Other Affiliations*

Annual Compensation*

Total Annual Compensationkr8,100,000

Stock Options*

All Other Compensationkr2,300,000

Total Compensation*

Total Annual Cash Compensationkr10,400,000
Total Short Term Compensationkr8,100,000
Other Long Term Compensationkr2,300,000
Total Calculated Compensationkr10,400,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr366.10 DKK -4.90


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at